ProShares UltraShort Bloomberg Natrl Gas

MicroSectors Gold Miners 3X Leveraged ETN

Direxion Daily Gold Miners Bull 3X ETF

VanEck Vectors Junior Gold Miners ETF

Direxion Daily Technology Bull 3X ETF

Direxion Daily 20+ Yr Trsy Bull 3X ETF

Bank Of Montreal

VanEck Vectors Gold Miners ETF

Direxion Daily Financial Bull 3X ETF

Direxion Dly S&P Oil&Gs Ex&Prd Br 3X ETF

ProShares Ultra Bloomberg Natural Gas

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

United States Natural Gas

Direxion Daily Gold Miners Bear 3X ETF

Direxion Technology Bear 3X Shares

Direxion Daily 20+ Yr Trsy Bear 3X ETF

Direxion Financial Bear 3X Shar

Direxion Dly S&P Oil&Gs Ex&Prd Bl 3X ETF

Juniper Networks Inc. Common Stock

Reddit Inc. Class A Common Stock

Ultrapar Participacoes S.A. (New) American Depositary Shares (Each representing one Common Share)

Carvana Co. Class A Common Stock

Whirlpool Corporation Common Stock

Restaurant Brands International Inc. Common Shares

Oracle Corporation Common Stock

Dana Incorporated Common Stock

New Gold Inc.

Gold Fields Limited American Depositary Shares

ChargePoint Holdings Inc. Common Stock

AgEagle Aerial Systems Inc. Common Stock

RE/MAX Holdings Inc. Class A Common Stock

RLJ Lodging Trust Common Shares of Beneficial Interest $0.01 par value

Quaker Houghton Common Stock

Bath & Body Works Inc.

Dick's Sporting Goods Inc Common Stock

Apple Hospitality REIT Inc. Common Shares

Boeing Company (The) Common Stock

Asbury Automotive Group Inc Common Stock

Click here to get full coverage on Denali Therapeutics Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution - simplywall.st

Denali Therapeutics Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution  simplywall.st

Denali Therapeutics Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution - simplywall.st

Click here to get full coverage on Denali Therapeutics: Navigating Through Recent Setbacks (NASDAQ:DNLI) - Seeking Alpha

Denali Therapeutics: Navigating Through Recent Setbacks (NASDAQ:DNLI)  Seeking Alpha

Denali Therapeutics: Navigating Through Recent Setbacks (NASDAQ:DNLI) - Seeking Alpha

Click here to get full coverage on Breakthrough Hunter Syndrome Drug Heads to FDA: Denali's Brain-Barrier Treatment Could Transform Patient Care - Stock Titan

Breakthrough Hunter Syndrome Drug Heads to FDA: Denali's Brain-Barrier Treatment Could Transform Patient Care  Stock Titan

Breakthrough Hunter Syndrome Drug Heads to FDA: Denali's Brain-Barrier Treatment Could Transform Patient Care - Stock Titan

Click here to get full coverage on Why Is Denali Therapeutics (DNLI) Up 0.7% Since Last Earnings Report? - Yahoo Finance

Why Is Denali Therapeutics (DNLI) Up 0.7% Since Last Earnings Report?  Yahoo Finance

Why Is Denali Therapeutics (DNLI) Up 0.7% Since Last Earnings Report? - Yahoo Finance

Click here to get full coverage on (DNLI) Proactive Strategies - news.stocktradersdaily.com

(DNLI) Proactive Strategies  news.stocktradersdaily.com

(DNLI) Proactive Strategies - news.stocktradersdaily.com

Click here to get full coverage on Denali Therapeutics Enters Registration Rights Agreement - TipRanks

Denali Therapeutics Enters Registration Rights Agreement  TipRanks

Denali Therapeutics Enters Registration Rights Agreement - TipRanks

Click here to get full coverage on Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome - GlobeNewswire

Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome  GlobeNewswire

Denali Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights Including Completion of BLA Rolling Submission for Tividenofusp Alfa for Hunter Syndrome - GlobeNewswire

Click here to get full coverage on What Happened To Denali Therapeutics Stock Wednesday? - Benzinga

What Happened To Denali Therapeutics Stock Wednesday?  Benzinga

What Happened To Denali Therapeutics Stock Wednesday? - Benzinga

Click here to get full coverage on Is Denali Therapeutics Inc. (DNLI) Among Jeff Bezos’ Investments in 2025? - Insider Monkey

Is Denali Therapeutics Inc. (DNLI) Among Jeff Bezos’ Investments in 2025?  Insider Monkey

Is Denali Therapeutics Inc. (DNLI) Among Jeff Bezos’ Investments in 2025? - Insider Monkey

Click here to get full coverage on Why You Shouldn't Bet Against Denali (DNLI) Stock - Yahoo Finance

Why You Shouldn't Bet Against Denali (DNLI) Stock  Yahoo Finance

Why You Shouldn't Bet Against Denali (DNLI) Stock - Yahoo Finance

Click here to get full coverage on Can Denali's Hunter Syndrome Drug Breakthrough Offset $422M Annual Loss? - Stock Titan

Can Denali's Hunter Syndrome Drug Breakthrough Offset $422M Annual Loss?  Stock Titan

Can Denali's Hunter Syndrome Drug Breakthrough Offset $422M Annual Loss? - Stock Titan

Click here to get full coverage on Denali Therapeutics: Vast Pipeline, First Approval Up Ahead (NASDAQ:DNLI) - Seeking Alpha

Denali Therapeutics: Vast Pipeline, First Approval Up Ahead (NASDAQ:DNLI)  Seeking Alpha

Denali Therapeutics: Vast Pipeline, First Approval Up Ahead (NASDAQ:DNLI) - Seeking Alpha

Click here to get full coverage on We're Not Very Worried About Denali Therapeutics' (NASDAQ:DNLI) Cash Burn Rate - simplywall.st

We're Not Very Worried About Denali Therapeutics' (NASDAQ:DNLI) Cash Burn Rate  simplywall.st

We're Not Very Worried About Denali Therapeutics' (NASDAQ:DNLI) Cash Burn Rate - simplywall.st

Click here to get full coverage on (DNLI) Investment Analysis - news.stocktradersdaily.com

(DNLI) Investment Analysis  news.stocktradersdaily.com

(DNLI) Investment Analysis - news.stocktradersdaily.com

Click here to get full coverage on Denali Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - GlobeNewswire

Denali Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights  GlobeNewswire

Denali Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights - GlobeNewswire

Click here to get full coverage on Breakthrough: Denali's Hunter Syndrome Drug Enters Final FDA Approval Stage - Stock Titan

Breakthrough: Denali's Hunter Syndrome Drug Enters Final FDA Approval Stage  Stock Titan

Breakthrough: Denali's Hunter Syndrome Drug Enters Final FDA Approval Stage - Stock Titan

Click here to get full coverage on Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report? - Yahoo Finance

Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report?  Yahoo Finance

Why Is Denali Therapeutics (DNLI) Down 21.2% Since Last Earnings Report? - Yahoo Finance

Click here to get full coverage on (DNLI) On The My Stocks Page - news.stocktradersdaily.com

(DNLI) On The My Stocks Page  news.stocktradersdaily.com

(DNLI) On The My Stocks Page - news.stocktradersdaily.com

Click here to get full coverage on Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire

Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights  GlobeNewswire

Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewswire

Click here to get full coverage on Denali Therapeutics begins marketing application for genetic disorder drug, shares rise - TradingView

Denali Therapeutics begins marketing application for genetic disorder drug, shares rise  TradingView

Denali Therapeutics begins marketing application for genetic disorder drug, shares rise - TradingView

Click here to get full coverage on Denali Q4 Earnings Beat Estimates, Hunter Syndrome Drug in Focus - Yahoo Finance

Denali Q4 Earnings Beat Estimates, Hunter Syndrome Drug in Focus  Yahoo Finance

Denali Q4 Earnings Beat Estimates, Hunter Syndrome Drug in Focus - Yahoo Finance

Click here to get full coverage on Denali Therapeutics Continues To Have Plenty Of Moving Parts (NASDAQ:DNLI) - Seeking Alpha

Denali Therapeutics Continues To Have Plenty Of Moving Parts (NASDAQ:DNLI)  Seeking Alpha

Denali Therapeutics Continues To Have Plenty Of Moving Parts (NASDAQ:DNLI) - Seeking Alpha

Click here to get full coverage on Denali Therapeutics Announces Key Anticipated 2025 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases - Yahoo Finance

Denali Therapeutics Announces Key Anticipated 2025 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases  Yahoo Finance

Denali Therapeutics Announces Key Anticipated 2025 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases - Yahoo Finance

Click here to get full coverage on Biotech Reverses Higher Despite A Misstep In ALS Treatment - Investor's Business Daily

Biotech Reverses Higher Despite A Misstep In ALS Treatment  Investor's Business Daily

Biotech Reverses Higher Despite A Misstep In ALS Treatment - Investor's Business Daily

Click here to get full coverage on Denali Therapeutics shares fall after price target cut to $32 - Investing.com

Denali Therapeutics shares fall after price target cut to $32  Investing.com

Denali Therapeutics shares fall after price target cut to $32 - Investing.com

Click here to get full coverage on Denali Therapeutics Discontinues DNL343 ALS Trial - TipRanks

Denali Therapeutics Discontinues DNL343 ALS Trial  TipRanks

Denali Therapeutics Discontinues DNL343 ALS Trial - TipRanks

Click here to get full coverage on Denali Therapeutics Announces Primary Analysis and Long-Term Follow-Up of Phase 1/2 Study in Hunter Syndrome (MPS II) with Tividenofusp Alfa - GlobeNewswire

Denali Therapeutics Announces Primary Analysis and Long-Term Follow-Up of Phase 1/2 Study in Hunter Syndrome (MPS II) with Tividenofusp Alfa  GlobeNewswire

Denali Therapeutics Announces Primary Analysis and Long-Term Follow-Up of Phase 1/2 Study in Hunter Syndrome (MPS II) with Tividenofusp Alfa - GlobeNewswire

Click here to get full coverage on Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In - Insider Monkey

Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In  Insider Monkey

Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In - Insider Monkey

Click here to get full coverage on Denali Therapeutics: A Promising Biotech With Revolutionary BBB-Crossing Technology - Seeking Alpha

Denali Therapeutics: A Promising Biotech With Revolutionary BBB-Crossing Technology  Seeking Alpha

Denali Therapeutics: A Promising Biotech With Revolutionary BBB-Crossing Technology - Seeking Alpha

Click here to get full coverage on Denali Therapeutics Announces Upcoming Presentations on - GlobeNewswire

Denali Therapeutics Announces Upcoming Presentations on  GlobeNewswire

Denali Therapeutics Announces Upcoming Presentations on - GlobeNewswire

Click here to get full coverage on Denali looks to scale new heights in quest for treatment for rare genetic disorder - San Francisco Business Times - The Business Journals

Denali looks to scale new heights in quest for treatment for rare genetic disorder - San Francisco Business Times  The Business Journals

Denali looks to scale new heights in quest for treatment for rare genetic disorder - San Francisco Business Times - The Business Journals

Click here to get full coverage on 5 Drug/Biotech Stocks Likely to Outperform Q1 Earnings Estimates - Yahoo Finance

5 Drug/Biotech Stocks Likely to Outperform Q1 Earnings Estimates  Yahoo Finance

5 Drug/Biotech Stocks Likely to Outperform Q1 Earnings Estimates - Yahoo Finance

Click here to get full coverage on Denali Q1 Loss Wider Than Expected, Hunter Syndrome Drug in Focus - Zacks Investment Research

Denali Q1 Loss Wider Than Expected, Hunter Syndrome Drug in Focus  Zacks Investment Research

Denali Q1 Loss Wider Than Expected, Hunter Syndrome Drug in Focus - Zacks Investment Research

Click here to get full coverage on Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights - Yahoo Finance

Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights  Yahoo Finance

Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights - Yahoo Finance

Click here to get full coverage on Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer - PR Newswire

Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer  PR Newswire

Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer - PR Newswire

Click here to get full coverage on Flagship Pioneering Debuts Enabling Technologies Initiative - PR Newswire

Flagship Pioneering Debuts Enabling Technologies Initiative  PR Newswire

Flagship Pioneering Debuts Enabling Technologies Initiative - PR Newswire

Click here to get full coverage on Flagship Pioneering Appoints Jason Gardner as CEO-Partner and CEO of Ampersand Biomedicines - PR Newswire

Flagship Pioneering Appoints Jason Gardner as CEO-Partner and CEO of Ampersand Biomedicines  PR Newswire

Flagship Pioneering Appoints Jason Gardner as CEO-Partner and CEO of Ampersand Biomedicines - PR Newswire

Click here to get full coverage on Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine - PR Newswire

Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine  PR Newswire

Flagship Pioneering and Samsung Announce Collaboration to Advance Groundbreaking Technologies in Translational Science and Medicine - PR Newswire

Click here to get full coverage on Flagship Pioneering Launches Pioneering Intelligence - PR Newswire

Flagship Pioneering Launches Pioneering Intelligence  PR Newswire

Flagship Pioneering Launches Pioneering Intelligence - PR Newswire

Click here to get full coverage on HC Wainwright & Co. Reiterates Denali Therapeutics (DNLI) Buy Recommendation - Nasdaq

HC Wainwright & Co. Reiterates Denali Therapeutics (DNLI) Buy Recommendation  Nasdaq

HC Wainwright & Co. Reiterates Denali Therapeutics (DNLI) Buy Recommendation - Nasdaq

Click here to get full coverage on Denali Therapeutics (DNLI) - Zacks Investment Research

Denali Therapeutics (DNLI)  Zacks Investment Research

Denali Therapeutics (DNLI) - Zacks Investment Research

Click here to get full coverage on 3 Longevity Stocks to Buy for Anti-Aging Breakthroughs - InvestorPlace

3 Longevity Stocks to Buy for Anti-Aging Breakthroughs  InvestorPlace

3 Longevity Stocks to Buy for Anti-Aging Breakthroughs - InvestorPlace

Click here to get full coverage on Denali (DNLI) Q1 Earnings Miss Estimates, Pipeline in Focus - Nasdaq

Denali (DNLI) Q1 Earnings Miss Estimates, Pipeline in Focus  Nasdaq

Denali (DNLI) Q1 Earnings Miss Estimates, Pipeline in Focus - Nasdaq

Click here to get full coverage on Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer - PR Newswire

Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer  PR Newswire

Flagship Pioneering Announces Appointment of Amanda Kay as Chief Business Development Officer - PR Newswire

Click here to get full coverage on Invaio achieves first registration for citrus greening solution featuring Trecise™ technology - PR Newswire

Invaio achieves first registration for citrus greening solution featuring Trecise™ technology  PR Newswire

Invaio achieves first registration for citrus greening solution featuring Trecise™ technology - PR Newswire

Click here to get full coverage on Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights - GlobeNewswire

Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights  GlobeNewswire

Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights - GlobeNewswire

Click here to get full coverage on Denali Therapeutics Announces $500 million Private Placement Equity Financing - GlobeNewswire

Denali Therapeutics Announces $500 million Private Placement Equity Financing  GlobeNewswire

Denali Therapeutics Announces $500 million Private Placement Equity Financing - GlobeNewswire

Click here to get full coverage on Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner - PR Newswire

Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner  PR Newswire

Flagship Pioneering Announces Appointment of David Khougazian as Growth Partner - PR Newswire

Click here to get full coverage on Denali Therapeutics (DNLI) Stock Price, News & Analysis - MarketBeat

Denali Therapeutics (DNLI) Stock Price, News & Analysis  MarketBeat

Denali Therapeutics (DNLI) Stock Price, News & Analysis - MarketBeat

Click here to get full coverage on Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics - PR Newswire

Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics  PR Newswire

Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics - PR Newswire

Click here to get full coverage on Higher educ for career advancement open for Davao Norte-based NGA, GOCC employees - Philippine Information Agency

Higher educ for career advancement open for Davao Norte-based NGA, GOCC employees  Philippine Information Agency

Higher educ for career advancement open for Davao Norte-based NGA, GOCC employees - Philippine Information Agency

Click here to get full coverage on Nasdaq Welcomes Denali Therapeutics, Inc. (NASDAQ: DNLI) to The Nasdaq Stock Market - Nasdaq

Nasdaq Welcomes Denali Therapeutics, Inc. (NASDAQ: DNLI) to The Nasdaq Stock Market  Nasdaq

Nasdaq Welcomes Denali Therapeutics, Inc. (NASDAQ: DNLI) to The Nasdaq Stock Market - Nasdaq

Click here to get full coverage on Denali Therapeutics Announces Key Anticipated 2024 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases - Stock Titan

Denali Therapeutics Announces Key Anticipated 2024 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases  Stock Titan

Denali Therapeutics Announces Key Anticipated 2024 Milestones and Priorities to Further Advance Its Therapeutics Portfolio for Neurodegeneration and Lysosomal Storage Diseases - Stock Titan

Click here to get full coverage on Bearish: Analysts Just Cut Their Denali Therapeutics Inc. (NASDAQ:DNLI) Revenue and EPS estimates - Yahoo

Bearish: Analysts Just Cut Their Denali Therapeutics Inc. (NASDAQ:DNLI) Revenue and EPS estimates  Yahoo

Bearish: Analysts Just Cut Their Denali Therapeutics Inc. (NASDAQ:DNLI) Revenue and EPS estimates - Yahoo

Click here to get full coverage on Denali Therapeutics Announces Closing of a $316 Million - GlobeNewswire

Denali Therapeutics Announces Closing of a $316 Million  GlobeNewswire

Denali Therapeutics Inc (DNLI)

Price Chart

Key Statistics

Technicals

About DNLI

Latest News

Denali Therapeutics Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution - simplywall.st

Denali Therapeutics: Navigating Through Recent Setbacks (NASDAQ:DNLI) - Seeking Alpha

Breakthrough Hunter Syndrome Drug Heads to FDA: Denali's Brain-Barrier Treatment Could Transform Patient Care - Stock Titan

Advanced Charts

Top Gainers

Top Losers